109145 ⎘
Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.
ORGANIC COMPOSITIONS TO TREAT HSF1-RELATED DISEASES
#3302Methods for promoting reinnervation of auditory hair cells
#3303Compositions and methods for transport across the blood brain barrier
#3304METHODS AND COMPOSITIONS RELATED TO CHITOSAN-DERIVED NANOPARTICLE-MEDIATED CRISPR/CAS9 DELIVERY
#3305Pharmaceutical compositions and methods for potentiating gene silencing
#3306Method of Encapsulating a Nucleic Acid in a Lipid Nanoparticle Host
#3307MIR-320E AND COLORECTAL CANCER
#3308Methods and Compositions for Selecting siRNA of Improved Functionality
#3309Oligonucleotide compositions with enhanced efficiency
#3310Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#3311Methods for preventing titration of bimolecular templated assembly reactions by structurally-determined differential hybridizations
#3312Compositions and methods for controlling insect pests
#3313Serpina1 iRNA compositions and methods of use thereof
#3314RAAV-based compositions and methods for treating amyotrophic lateral sclerosis
#3315Double-stranded nucleic acid inhibitor molecules modified with Tm-increasing nucleotides
#3316SEMAPHORIN 3D AND PLEXIN D1 AS THERAPEUTIC TARGETS FOR PANCREATIC CANCER TREATMENT
#3317Compositions for in vivo Expression of Therapeutic Sequences in the Microbiome
#3318Carrier Nanoparticles And Related Compositions, Methods And Systems
#3319TREATMENT OF HORMONAL DISORDERS OF GROWTH
#3320NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE
#3321NOVEL TARGET FOR ANTI-CANCER AND IMMUNE-ENHANCING
#3322Method of treating cancer and method of sensitizing cancer cells to the action of chemotherapeutic agents via growth hormone receptor antagonists or knock down
#3323RNAi constructs for inhibiting ASGR1 expression and methods of use thereof
#3324Allele-specific silencing therapy for Dynamin 2-related diseases
#3325Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
#3326Compositions and methods for improving immune system function
#3327Inhibitors of cytoplasmic histone deacetylase 4 complex for treating or preventing vascular or valve calcification
#3328Method for the diagnosis, prognosis and treatment of cancer metastasis
#3329Methods and compositions for the treatment of cancer
#3330Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
#3331Process of delivering small RNAs to sperm
#3332Compositions and Methods for Inhibiting Expression of Transthyretin
#3333CCCTC-binding factor (CTCF) RNA interactome
#3334Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway
#3335Antibodies and fragments thereof that bind hepatitis B virus protein X
#3336Recombinant protein-based method for the delivery of silencer RNA to target the brain
#3337Non-enzymatic, salt-mediated synthesis of polynucleic acids
#3338Compositions and methods for reducing neointima formation
#3339Use of leucine-zipper protein for diagnosis or treatment of fatty liver
#3340A NOVEL ROLE FOR TERMINAL RNA URIDYLATION AND RNA TURNOVER IN ONCOGENESIS
#3341Method of treatment
#3342METHODS AND MODIFICATIONS THAT PRODUCE ssRNAi COMPOUNDS WITH ENHANCED ACTIVITY, POTENCY AND DURATION OF EFFECT
#3343METHODS AND COMPOSITIONS FOR T-RNA BASED GUIDE RNA EXPRESSION
#3344Compositions and methods of treating muscle atrophy and myotonic dystrophy
#3345Angiotensinogen (AGT) iRNA compositions and methods of use thereof
#3346Methods for treatment of cancer by targeting SIRT5
#3347Compositions and methods for treating pulmonary vascular disease
#3348RNAi insecticide materials and methods
#3349Repressors of viral infection
#3350ASSAYS AND METHODS FOR DETERMINING ACTIVITY OF A THERAPEUTIC AGENT IN A SUBJECT
#3351Compositions for transfecting resistant cell types
#3352Methods of identifying and treating poor-prognosis cancers
#3353RNAi agents for Hepatitis B virus infection
#3354SINGLE-CHAIN CIRCULAR RNA AND METHOD OF PRODUCING THE SAME
#3355Prokaryotic Argonaute Proteins and Uses Thereof
#3356METHODS FOR CANCER STEM CELL (CSC) EXPANSION
#3357KLRG1 antagonist signaling therapy
#3358Cationic lipids for nucleic acid delivery and preparation thereof
#3359PHARMACEUTICAL ASSOCIATION OF GROWTH FACTOR RECEPTOR AGONIST AND ADHESION PROTEIN INHIBITOR FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF
#3360Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3361Fidgetin-like 2 as a target to enhance wound healing
#3362TMPRSS6 iRNA compositions and methods of use thereof
#3363E. COLI MEDIATED siRNA SILENCING OF AVIAN INFLUENZA IN CHICKENS
#3364Compositions and methods for inhibiting gene expression of alpha-1 AntiTrypsin
#3365DOSAGES AND METHODS FOR DELIVERING LIPID FORMULATED NUCLEIC ACID MOLECULES
#3366Gene-regulating compositions and methods for improved immunotherapy
#3367GENE-REGULATING COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY
#3368Methods of promoting CNS neuronal repair by inhibiting LRP-1
#3369Compositions and methods for promoting the mineralization of biological tissue
#3370METHODS OF USING ZSCAN4 FOR REJUVENATING HUMAN CELLS
#3371Methods of using ZSCAN4 for rejuvenating human cells
#3372Viral vectors for treating Parkinson's disease
#3373Treatment methods for fibrosis targeting SMOC2
#3374Treatment of synucleinopathies
#3375Disruption of EGFR-SAR1 interaction for cancer treatment
#3376CANCER TREATMENT BY GLYCEROL-3-PHOSPHATE DEHYDROGENASE 1 INHIBITION
#3377Novel Paratransgenic System for the Biocontrol of Disease-Transmitting Mosquitos
#3378Organic compositions to treat HSF1-related diseases
#3379RAAV-based compositions and methods for treating amyotrophic lateral sclerosis
#3380Cancer Treatment and Immune System Regulation Through FAT10 Pathway Inhibition
#3381METHODS OF TREATEMENT OF CANCER DISEASE BY TARGETTING TUMOR ASSOCIATED MACROPHAGE
#3382Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3383COMPOSITIONS AND METHODS FOR THE SUPPRESSION OF TARGET POLYNUCLEOTIDES FROM LEPIDOPTERA
#3384Methods and Compositions for Selecting siRNA of Improved Functionality
#3385METHODS OF CONTROLLING RED BLOOD CELL PRODUCTION
#3386Nanoparticles comprising protein-polynucleotide complexes and for delivering protein based complexes
#3387Integrin alpha 9 blockade suppresses lymphatic valve formation and promotes transplant survival
#3388Methods for non-myeloablative bone marrow reconstitution
#3389Nanoparticles for chemotherapy, targeted therapy, photodynamic therapy, immunotherapy, and any combination thereof
#3390USE OF H2A.Z.1 AS A HEPATOCELLULAR CARCINOMA BIOMARKER
#3391Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3392Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3393Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3394Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3395Agents for improved delivery of nucleic acids to eukaryotic cells
#3396Modulation of gene expression and screening for deregulated protein expression
#3397Therapeutic compositions
#3398GLYCOCONJUGATES OF RNA INTERFERENCE AGENTS
#3399Generic System of Antisense Oligonucleotide
#3400CCR7 aptamers and uses thereof
#3401Antibodies specific for LOX1 and use in treatment of cardiovascular disorders
#3402Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3403Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3404Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3405AAV delivery of shRNA for treatment of pancreatic cancer
#3406Methods of modulating melanosome pH and melanin level in cells
#3407RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
#3408DOWN-REGULATING GENE EXPRESSION IN INSECT PESTS
#3409Targeting ligands
#3410Modulation of TJP1 expression to regulate regeneration of heart cells
#3411Therapeutic targets involved in the progression of nonalcoholic steatohepatitis (NASH)
#3412METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION
#3413RNAi AGENTS FOR HEPATITIS B VIRUS INFECTION
#3414EGFR gene expression-suppressing siRNA, precursor of same, and applications thereof
#3415Fibrotic treatment
#3416Antisense compounds and uses thereof
#3417Recombinant virus products and methods for inhibition of expression of myotilin
#3418Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
#3419Alpha-v beta-6 integrin ligands and uses thereof
#3420Branched oligonucleotides
#3421Methods and pharmaceutical compositions for the treatment of systemic mastocytosis
#3422METHODS AND MATERIALS FOR ACTIVATING MUSCLE REMODELING
#3423Modulators of DNM2 expression
#3424MOLECULAR RE-ENGINEERING OF EXCITATION-INHIBITION BALANCE IN MEMORY CIRCUITS
#3425Modified double-stranded RNA agents
#3426Modified double-stranded RNA agents
#3427METHODS OF INHIBITING METASTASIS IN CANCER
#3428Functionalized nucleic acid nanostructures for RNA delivery
#3429Lipid formulations for delivery of therapeutic agents
#3430Methods of treating a wound using epigenetic regulation
#3431RNA interference in ocular indications
#3432RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#3433Method of releasing the suppression of egg maturation in economically-important prawn/shrimp species
#3434Organic compositions to treat APOC3-related diseases
#3435KIDNEY DISEASE TARGETS AND USES THEREOF
#3436COMPOSITIONS AND METHODS FOR TARGETING FRUCTOSE ENZYMES AND TRANSPORTERS FOR THE TREATMENT OF CANCER
#3437Compositions and methods for nanoparticle lyophile forms
#3438METHOD AND KIT FOR DETERMINING PROGNOSIS, REMOTE RECURRENCE RISK AND INVASION OF GLIOMA, AND PHARMACEUTICAL COMPOSITION FOR TREATING GLIOMA
#3439Intrathecal delivery of nucleic acid sequences encoding ABCD1 for treatment of adrenomyeloneuropathy
#3440Oligonucleotide compounds for targeting huntingtin mRNA
#3441MODULATION OF FUNCTION OF IMMUNE EFFECTOR CELLS
#3442REDUCING CUTANEOUS SCAR FORMATION AND TREATING SKIN CONDITIONS
#3443Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
#3444Exosomes and miRNA to treat glaucoma
#3445Adeno-associated virus virions with variant capsid
#3446Methods and compositions for monitoring and enhancing early embryo development
#3447siRNA knocking down human PD-1 and recombinant expression CAR-T vector and their construction methods and applications
#3448Therapeutic compositions and methods of making and using the same
#3449INHIBITION OF PCSK9 THROUGH RNAI
#3450Methods and compositions for the specific inhibition of complement component 5(C5) by double-stranded RNA
#3451COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
#3452Method for producing N-acetylglucosamine by co-utilizing glucose and xylose based on CRISPRi
#3453TRPM4 CHANNEL INHIBITORS FOR STROKE TREATMENT
#3454ANTIMICROBIAL PEPTIDE DERIVATIVE AND USE THEREOF
#3455DELIVERY OF NUCLEIC ACIDS, PROTEINS AND SMALL MOLECULES IN VITREOUS VESICULAR BODIES
#3456Nucleic acid molecules for reduction of PAPD5 or PAPD7 mRNA for treating hepatitis B infection
#3457Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof
#3458TMPRSS6 iRNA compositions and methods of use thereof
#3459Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#3460Modulators of telomere disease
#3461Neutral nanotransporters
#3462Targeting Ligands For Therapeutic Compounds
#3463RNA PRODUCTS AND USES THEREOF
#3464Short hairpin RNA compositions, methods of making and applications thereof
#3465NOVEL EGFR VARIANT
#3466METHODS AND COMPOSITIONS FOR EXPANSION OF HEMATOPOIETIC STEM AND/OR PROGENITOR CELLS EMPLOYING A CYTOCHROME P450 1B1 (CYP1B1) INHIBITOR OR A MUSASHI-2 (MSI2) ACTIVATOR
#3467ErbB2 regulates autophagic flux to modulate the proteostasis of APP-CTFs in alzheimer's disease
#3468METHOD FOR PREDICTING RESPONSIVENESS TO PHOSPHATIDYLSERINE SYNTHASE 1 INHIBITOR
#3469Therapeutic targets for Alzheimer's disease
#3470Methods and compositions for targeting RNA polymerases and non-coding RNA biogenesis to specific loci
#3471TREATMENT AND PREVENTION OF VIRAL INFECTION
#3472Increasing ATOH1 life to drive sensorineural hair cell differentiation
#3473Method of Modulating Fibroblast Accumulation or Collagen Deposition
#3474Anabolic Enhancers for Ameliorating Neurodegeneration
#3475Compositions and methods for controlling arthropod parasite and pest infestations
#3476Production of viruses in avian eggs
#3477Genetically-modified cells and method for producing same
#3478METHOD OF TREATING SYSTEMIC FIBROTIC DISORDERS USING AN IL-33/TNF BISPECIFIC ANTIBODY
#3479Polynucleotide constructs
#3480Aptamer compositions and methods of use thereof
#3481HIV pre-immunization and immunotherapy
#3482COMPOSITIONS AND METHODS RELATING TO C5L2
#3483SiRNA of human IL-6 and recombinant expression CAR-T vector and their construction methods and applications
#3484PAPD5 and PAPD7 inhibitors for treating a hepatitis B infection
#3485Nucleus-encoded male sterility through mutation in cytochrome P450 oxidase
#3486Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
#3487Use of Rad18 inhibitors in the treatment of tumors
#3488Inhibitors of SRSF1 to treat neurodegenerative disorders
#3489RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA)
#3490RNA modulating oligonucleotides with improved characteristics for the treatment of Duchenne and Becker muscular dystrophy
#3491Gene delivery carrier
#3492PLGA-modified polyethylenimine self-assembly nanotechnology for nucleic acid and drug delivery
#3493RNA/DNA HYBRID NANOPARTICLES MODIFIED WITH SINGLE STRANDED RNA TOEHOLDS AND USES THEREOF
#3494Pharmaceutical composition containing mTOR inhibitor for treating macular degeneration
#3495Compositions and methods for treating and preventing metabolic disorders
#3496Lipid-derived neutral nanoparticles
#3497Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3)
#3498Multi-conjugate of SiRNA and preparing method thereof
#3499Conjugated oligonucleotides
#3500THERAPEUTICALLY MODULATING APOB AND APOAI
#3501Use of regulatory T cell-specific surface protein LRIG-1
#3502MARKER FOR THE CLASSIFICATION, DIAGNOSIS AND TREATMENT OF SCOLIOSIS
#3503Production of itaconic acid
#3504Nucleic acid molecules inducing RNA interference, and uses thereof
#35054'-phosphate analogs and oligonucleotides comprising the same
#3506METHOD OF REGULATING GENE EXPRESSION
#3507Site-specific crosslinking of antibodies
#3508Method of screening a candidate compound for activity as an elastase 2A (ELA2A) inhibitor
#3509Compositions comprising reversibly modified oligonucleotides and uses thereof
#3510Aminoalcohol lipidoids and uses thereof
#3511Compositions and methods for treating viral infections in shrimps
#3512Loading of Extracellular Vesicles through Imparting of Mechanical Shear
#3513Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3514METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#3515METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#3516METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#3517METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
#3518Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3519Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3520Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3521Methods and compositions or RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3522Treatment of HER2-Dependent Cancers by SORL1 Inhibition
#3523Modulatory polynucleotides
#3524Modulation of BCL11A for treatment of hemoglobinopathies
#3525MODULATION OF TRANSTHYRETIN EXPRESSION
#3526DsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups
#3527Modified RNAi polynucleotides and uses thereof
#3528COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#3529Treating metastatic cancer and model systems for metastatic disease
#3530TLR9 TARGETED CYTOTOXIC AGENTS
#3531Lipids and compositions for the delivery of therapeutics
#3532Conjugated lipomers and uses thereof
#3533Methods of treating conditions involving elevated inflammatory response
#3534Methods of treating transthyretin (TTR) mediated amyloidosis
#3535CACTUS NUCLEIC ACID MOLECULES TO CONTROL COLEOPTERAN PESTS
#3536Reduced size self-delivering RNAI compounds
#3537HCMV entry inhibitors
#3538Means and methods to treat dystonia
#3539Targeted nucleic acid conjugate compositions
#3540Exosome-based therapeutics against neurodegenerative disorders
#3541Compositions and methods for treating Huntington's disease
#3542Integrated nano system for liver-targeting co-delivery of genes/drugs and preparation method
#3543Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
#3544Compositions and methods for treating cancer
#3545Inhibitory RNA-based therapeutics targeting ANLN for cancer treatment
#3546Composition for delivery of genetic material
#3547METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA
#3548Method for significantly increasing lentiviral production
#3549Process for formulating an anionic agent
#3550Treatment and prevention of atherothrombosis by inhibition of bruton's tyrosine kinase (BTK)
#3551Compositions and methods for inhibiting expression of the ALAS1 gene
#3552Allele-specific gene suppression
#3553Products and methods for treatment of familial amyotrophic lateral sclerosis
#3554RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
#3555RNAi induced huntingtin gene suppression
#3556Methods and compositions for the specific inhibition of transthyretin (TTR) by double-stranded RNA
#3557Nucleic acid molecules encoding antibodies to the human glucagon receptor
#3558METHODS FOR TREATING GLIOBLASTOMA OR RECURRENT GLIOBLASTOMA UTILIZING A WIRELESS SIGNAL ALONE OR IN COMBINATION WITH ONE OR MORE CANCER DRUGS, AND ASSOCIATED SYSTEMS, APPARATUSES, AND DEVICES
#3559Functionalized Nanoparticles and Compositions for Cancer Treatment and Methods
#3560HPV particles and uses thereof
#3561Methods involving Menain screening for inhibitors of cancer invasion and metastasis
#3562METHODS OF CONTROLLING VEGETATIVE GROWTH AND FLOWERING TIMES BY MODULATING PHOSPHOENOLPYRUVATE SHUNT BETWEEN SHIKIMATE AND GLYCOLYSIS PATHWAYS
#3563Method for preventing or treating obesity by using a composition including HOGA1-inhibiting substance and method of screening a preventive or therapeutic agent for obesity by using the composition
#3564Compositions and methods for manipulation of adipocyte energy consumption regulatory pathway
#3565Arrays of memory cells individually comprising a capacitor and an elevationally-extending transistor, methods of forming a tier of an array of memory cells, and methods of forming an array of memory cells individually comprising a capacitor and an elevationally-extending transistor
#3566Cell based anti-cancer compositions with reduced toxicity and methods of making the same
#3567RNA CONSTRUCTS
#3568Targeting the Steroidogenic Pathway For Treating and/or Preventing Allergic Diseases
#3569SINGLE-STRANDED RNAI OLIGONUCLEOTIDES TARGETING APOC-III
#3570Lysosomal degradation of lipids and proteins and method of use thereof
#3571ANTI-CANCER USE OF GENETICALLY MODIFIED HUMAN UMBILICAL CORD PERIVASCULAR CELLS (HUCPVC)
#3572Microbial oil containing fatty acids obtained from stramenopile and method of producing the same
#3573Compositions and methods for inhibiting expression of TMPRSS6 gene
#3574Methods for improving cognitive function via modulation of quinone reductase 2
#3575miRNA for treatment of breast cancer
#3576NOVEL NON-CODING RNA, CANCER TARGET AND COMPOUNDS FOR CANCER TREATMENT
#3577Nucleic acid linked to a trivalent glycoconjugate
#3578COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE
#3579SMALL INTERFERENCE RNA COMPLEX WITH INCREASED INTRACELLULAR TRANSMISSION CAPACITY
#3580Inhibitors of metastasis
#3581Methods for the treatment of cardiac hypertrophy
#3582EFFICIENT PROTEIN EXPRESSION IN VIVO USING MODIFIED RNA (MOD-RNA)
#3583Methods for treating renal disease
#3584Targeting AMP deaminase 2 for ameliorating craving for sugar and other substances
#3585MICROFLUIDIC-FORMULATED LEUKOSOME COMPOSITIONS AND FABRICATION METHODS THEREFOR
#3586Use of exosomes for the treatment of disease
#3587Endomucin inhibitor as an anti-angiogenic agent
#3588Cancer therapy
#3589Methods and compositions for managing vascular conditions using miR-483 mimics and HIF1alpha pathway inhibitors
#3590CONDITIONAL PROTEIN TRANSLATION SWITCHES, CONDITIONAL GENE EXPRESSION SYSTEMS AND USES THEREOF
#3591Exosome transfer of nucleic acids to cells
#3592NOVEL CANCER ANTIGEN EEF2
#3593Method for promoting muscle regeneration
#3594Methods and compositions for modulating gossypol content in cotton plants
#3595EVALUATION OF THE SEVERITY OF PATIENTS WITH FLAVIVIRUS INFECTION BY BLOOD HYALURONAN LEVELS AND THERAPEUTIC AGENTS TO BLOCK THE HYALURONAN
#3596Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3597Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3598Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3599Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#3600Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription